In this study, we determined the anti-infl ammatory activity and mechanism of action of a hexane fraction (hWRF) obtained from white Rosa hybrida fl owers by employing various assays such as quantitative real-time PCR, Western blotting, and Electrophoretic-Mobility Shift Assay (EMSA). The results revealed that the hWRF had excellent anti-infl ammatory potency by reducing infl ammatory repertoires, such as inducible nitric oxide synthase (iNOS), interleukin-1β, and cyclooxygenase-2 (COX-2) in RAW264.7 cells when stimulated with lipopolysaccharide (LPS), a pro-infl ammatory mediator. The reduction of nitric oxide (NO) release from RAW 264.7 cells supported the anti-infl ammatory effect of hWRF. Interestingly, hWRF effectively inhibited LPS-mediated nuclear factor-κB (NF-κB) p65 subunit translocation into the nucleus and extracellular signal-regulated kinase (ERK)1/2 phosphorylation, suggesting that hWRF anti-infl ammatory activity may be based on inhibition of the NF-κB and MAPK pathways. Based on the fi ndings described in this study, hWRF holds promise for use as a potential anti-infl ammatory agent for either therapeutic or functional adjuvant purposes. Abstract which contribute to their chemopreventive potential (Surh et al., 2001) . Moreover, natural anti-infl ammatory or immunomodulatory plant metabolites, which are abundant in fractionated extracts, have therapeutic effects against various chronic diseases, by inducing or suppressing specifi c cellular infl ammatory activities and the associated molecular signaling pathways (Aravindaram and Yang, 2010) . Some polyphenols, such as catechines from green tea, appear to be the primary bioactive compounds in the suppression of key cytokines that are secreted during the infl ammation cascade (De Mjia et al., 2009; Gosslau et al., 2011a) . The rose (genus Rosa), allied to its use as a source of aromatic oils for the perfume industry, has been an alternative model for pharmaceutical candidates to treat diabetes mellitus, pain, and infl ammatory diseases (Cho et al., 2003; Ng et al., 2005) . Previously, we reported that the hexane fraction from white rose fl owers, which may contain high amounts of
INTRODUCTION
For decades, many studies have shown that pharmacologically active compounds are present in various plants and can act as special metabolites that allow plants to interact with factors found in its environment, such as plant-insect, plantmicroorganism and plant-plant interactions (Dixon, 2001; Harborne, 2001; Argolo et al., 2004) . Among the several small molecules retained in plants, polyphenols (hydrolysabletannins/phenylpropanoids) are the most abundant antioxidants in our diet and have been shown to play a possible role in the prevention several chronic diseases (Bravo, 1998; Hotta et al., 2002; Gosslau et al., 2011b) . Polyphenol antioxidants, such as resveratrol, inhibit the occurrence and/or growth of mammalian tumors (Jang et al., 2008) , and a wide variety of phenolic substances derived from plants have been shown to display marked antioxidant and anti-infl ammatory activities, gallic acid and volatiles (1-butanol, dodecyl acrylate and cyclododecane), displayed a broad range of anti-oxidant, antimicrobial and anti-allergic effects Joo et al., 2010) . In the present study, we examined the anti-infl ammatory properties of the hexane fraction from the white rose fl ower, which may be used as a natural source of bioactive compounds.
MATERIALS AND METHODS

Preparation of hexane fraction (hWRF)
Finely ground fl ower powders (410 g) were extracted with methanol at room temperature for 24 h. The ratio of fl ower powder to solvent was 1:20 (w/v). The resulting slurries were fi ltered through Whatman no. 1 fi lter paper. This procedure was repeated twice for the residue, and the fi ltrates were combined. All of the fi ltrates were collected and concentrated under vacuum at 50 o C and freeze-dried (54% yield). The freezedried methanol extract (1 g) was then redissolved in methanol (1.5 ml), and 20 ml of water was added (methanol/water, 1.5:20, v/v) . This mixture was then sequentially partitioned with hexane and butanol (same solvent ratio as water). Three resulting fractions (H 2 O, butanol, and hexane layer) were obtained, evaporated to dryness under vacuum, and used directly in the anti-infl ammatory tests. The hexene fraction was dissolved in 10% DMSO, and stock solutions were prepared at high concentrations so that the fi nal DMSO concentration was not higher than 0.1% during all experiments.
Cell culture
Raw 264.7 (Mouse leukaemic monocyte macrophage cell line) cells were grown in Dulbecco's Modifi ed Eagle's Medium (DMEM) (Hyclone, Logan, UT, USA) supplemented with 10% FBS, 4 mM/L L-glutamate (Invitrogen, Carlsbad CA, USA), 100 U/ml penicillin and 100 μg/ml streptomycin (Invitrogen). Cultures were maintained under 5% CO 2 at 37 o C in tissue culture fl asks. For all experiments, the cells were grown to greater than 90% confl uency and subjected to no more than 20 cell passages.
Cellular Cytotoxicity (lactate dehydrogenase) assay
The cytotoxicity induced by hWRF was quantifi ed by measuring lactate dehydrogenase (LDH) release by RAW 264.7 cells. The LDH content was determined using a commercial non-radioactive LDH assay kit (Promega, Madison, WI, USA), which is based on a coupled enzymatic reaction that converts tetrazolium salt into a red formazan product. The increase in the amount of formazan produced in the culture supernatant directly correlates with the increase in the number of lysed cells. The formazan was quantifi ed spectrophotometrically by measuring the absorbance at 490 nm (Molecular Devices, Sunnyvale, CA, USA).
Nitric oxide (NO) production in RWA 264.7 RAW 264.7 cells (1×10 6 cells/ml) were seeded on a 24-well tissue culture plate and pre-incubated at 37 o C for 12 h to achieve stable attachment. The wells were then washed with phosphate buffered saline (PBS) after pre-incubation, refreshed with 1% FBS DMEM containing the samples (lipopolysaccharide (LPS), ascorbic acid (Asc), and hWRF (0.1 to 10 μg/ml)) and incubated for 24 h. NO production was then monitored by measuring nitrite levels in the culture media using the Griess reagent (Promega).
Quantitative real-time polymerase chain reaction (PCR)
Total RNA extracts from RAW 264.7 cells were stimulated by LPS, which was prepared by the Trizol method (Invitrogen). cDNA was synthesized from RNA by the reverse transcription of 1 μg of total RNA using the Improm-II reverse transcription system (Promega) and oligo dT primers in a total volume of 20 μl. PCR amplifi cation was performed using the primers shown in Table 1 (Bioneer, Deajeon, Korea). Quantitative realtime PCR reactions were run on a Rotor-Gene 6000 (Corbett Research, Sydney, Australia) using SYBR Green PCR Master Mix (Qiagen, Valencia, CA, USA) in 20 μl reaction mixtures. Each real-time-PCR master mix contained 10 μl 2X enzyme mastermix, 7.0 μl RNase free water, 1 μl of each primer (10 pM each) and 1 μl diluted template. PCR was performed with an initial pre-incubation step for 10 min at 95 o C, followed by 45 cycles of 95 o C for 15 s, annealing at 52 o C for 15 s and extension at 72 o C for 10 s. Melting curve analysis was used to confi rm formation of the expected PCR product, and products from all assays were subjected to 1.2% agarose gel electrophoresis to confi rm that they had the correct lengths. An interrun calibrator was used, and a standard curve was created for each gene to obtain PCR effi ciencies. Relative sample expression levels were calculated using Rotor-Gene 6000 Series Software 1.7, and were expressed relative to β-actin and corrected for between run variability. Data for the experimental samples were expressed as the percentage of the internal control gene.
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Electrophoretic-mobility shift (EMSA) assay
Nuclear extracts for EMSA were prepared from RAW 264.7 cells using Nuclear Extraction Reagents (Pierce, IL, USA) according to the manufacturer's instructions. EMSA was performed using the Panomics EMSA kit (Panomics, Fremont, CA, USA). In brief, nuclear extracts containing equal amounts of proteins for each sample were incubated with poly (dI-dC) (1 μg/μl) for 5 min, followed by the addition of binding buffer (20 mM HEPES pH 7.9, 1 mM DTT, 0.1 mM EDTA, 50 mM KCl, 5% glycerol and 200 μg/ml BSA) and biotinylated oligo (10 ng/μl). To control for the specifi city of binding for selected samples, a 5-fold excess of unlabeled oligo was added prior to the addition of the biotinylated probe. Binding reaction mixtures were incubated for 30 min at room temperature. Protein-DNA complexes were separated on 6% non-denaturing polyacrylamide gel in 0.5X Tris-borate/EDTA buffer (0.1 M Tris, 0.09 M boric acid containing 1mM EDTA) at 4 o C. After electrophoresis, the gels were transferred to a positively charged nylon transfer membrane (Amersham Bioscience, Piscataway NJ, USA). Transferred oligos were immobilized by UV crosslinking for 10 min. To detect bound oligos, membranes were blocked using blocking buffer (Panomics EMSA Gel-Shift Kit). Streptavidin-HRPO was then added and blots were developed by ECL according to the manufacturer's instructions (Amersham Bioscience).
Western blot analysis
RAW 264.7 cells were lysed in 1% RIPA buffer containing protease and phosphatase inhibitors (Roche, Mannheim, Germany) and whole cell lysates were separated by 10% SDS-PAGE. After electrophoresis, proteins were transferred onto polyvinylidene fl uoride (PVDF) membranes and the membranes were blocked with 5% skim milk in Tris-buffered saline solution containg 0.1% Tween-20. The membrane was then immunoblotted with primary antibodies, anti-iNOS, antiextracelullar signal-regulated protein kinase, anti-phospho-ERK and anti-Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Santa Cruz Biotechnology, CA, USA), which was followed by incubation with horseradish peroxidase-conjugated anti-rabbit or anti-mouse secondary antibodies (Stressgen, CA, USA). Blots were developed using an ECL solution. Densitometric measurements were conduction using the Gelquant software (MiniBIS Pro, Jerusalem, Israel).
Statistical analysis
The statistical analyses used to determine the differences between the groups included a one-way ANOVA with a Dunnet's post-hoc test, which was performed using the SPSS software (v. 13). Statistical signifi cance was set a priori at p<0.05.
RESULTS
To investigate the cytotoxicity of hWRF, RAW 264.7 cells were incubated with various concentrations of hWRF (0.01 to 100 μg/ml). As shown in Fig. 1 , hWRF was not cytotoxic up to 24 hours at concentrations lower than 10 μg/ml; however, a signifi cant increase in LDH release from the cells was observed at higher concentrations (100 μg/ml), indicating that these higher concentrations were cytotoxic. Because the cytotoxicity of hWRF at 100 μg/ml was so large, higher concentrations were not tested. Additionally, to stimulate NO production in RAW 267.4 cells, 1 μg/ml LPS was added and varying concentrations of the cells were co-treated with hWRF (0.1 to 10 μg/ml) for up to 24 h. As shown in Fig. 2 , hWRF signifi cantly inhibited NO production at concentrations ranging from 1 to 10 μg/ml (p<0.001), which was more effective than ascorbic acid (p<0.01). Fig. 3 clearly demonstrates that hWRF can effectively control the expression of those pro-infl ammatory mediators and repertoires, suggesting that hWRF can down-regulate LPS-induced iNOS, IL-1β and COX-2 expression at the transcriptional level. To determine whether the anti-infl ammatory activities of hWRF are mediated through the MAP kinase pathway, LPS-induced phosphorylation of ERK was analyzed. In addition, the protein levels of iNOS were also analyzed by immunoblotting. As shown in Fig. 4A , phosphoylated ERK was effectively attenuated, and iNOS were coincidently reduced in the presence of hWRF. To confi rm that hWRF might be correlated with the inhibition of NF-κB activation, we examined translocation of NF-κB p65 subumit into the nucleus, which binds to specifi c DNA sequences. Fig. 4B revealed that hWRF effectively inhibited binding to specifi c NF-κB p65 DNA se- seeded on a 96-well culture plate, treated with hWRF (0.1 to 10 μg/ ml), and incubated for 24 h. Ascorbic acid (100 μM) was used as a positive control, and LPS (1 μg/ml) was used as a cell stimulator. The presence of NO was detected using the Griess reagent and measured at 540 nm. The experiments were performed in triplicate and the results are expressed as the mean ± SD. *p<0.05, ***p< 0.001 compared with positive control, LPS. 10.4062/biomolther.2011.19.3.331 quences, which strongly suggests that hWRF effectively attenuated LPS-induced expression of pro-infl ammatory proteins.
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DISCUSSION
In our previous study, we determined that the hexane fraction of the white rose fl ower extract contained various functional volatiles (Table 2 ) and the abundant amount of total polyphenols (330.3 ± 20.1 mg of gallic acid equival/g of dry weight), which was approximately 2-fold higher than the amount observed in the butanol fraction and 2.6-fold higher than the amount observed in the water fraction Joo et al., 2010) . These results suggested that the hexane fraction from white rose fl ower extracts may have a more potent functional activity and, thus, was selected for more indepth anti-infl ammatory analysis (Joo et al., 2010) .
The primary anti-infl ammatory evidence was shown in NO inhibition assay in RAW 264.7 cells, suggesting that hWRF may control NO concentration at the cellular level by inhibiting NO production (Fig. 2) . NO and prostaglandin E 2 have been shown to be closely involved in the development of infl ammation, and these two infl ammatory mediators are associated with the expression iNOS and COX-2 (Sautebin, 2000) . Moreover, IL-1β is also a well-known pro-infl ammatory cytokine. Results revealed that hWRF can effectively control the expression of those pro-infl ammatory mediators and repertoires, suggesting that hWRF can down-regulate LPS-induced iNOS, IL-1β and COX-2 expression at the transcriptional level (Fig. 3,  4 ) (Warner et al., 1995) . These results were confi rmed by the attenuation of ERK phosphorylation and a coincident reduction of iNOS when treated with hWRF (Fig. 4A) . The NF-κB transcription factor has been shown to play an important role in LPS-induced expression of pro-infl ammatory proteins (Xie et al., 1994; Nagano et al., 1998; Lee, 2011) . Thus, to investigate the molecular mechanism of hWRF-mediated inhibition of pro-infl ammatory repertoires, such as iNOS and IL-1β, NF-κB transcription activity was investigated using immunoblot analysis of NF-κB p65 with the EMSA supershift assay (Fig.  4B) . At the molecular level, hWRF appreciably controlled the expression of infl ammatory repertoires by inhibiting the activation of NF-κB, which can induce the overexpression of proinfl ammatory cytokine genes in the nucleus, thereby effectively attenuate LPS-induced expression of pro-infl ammatory proteins. Since inhibition of NF-κB has been reported to be an effective approach for the treatment of infl ammatory disorders (Karin et al., 2004) , hWRF, which interfered with NF-κB signal transduction, may be a good therapeutic candidate for treatment of infl ammation. In turn, hWRF may inhibit iNOS, COX-2 expression and the pro-infl ammatory related genes by preventing the nuclear translocation of the p65subunit of NF-κB. Since macrophages play a central role in the host's defense against bacterial infection due to their phagocytic, cytotoxic, and intracellular killing capacities (Adams and Hamilton, 1984) , hWRF may be used for the treatment of a broad range of infl ammatory disorders, including topical infl ammation and worsening chronic dermatitis, such as atopic dermatitis ).
In conclusion, our results suggest that hWRF may be a favorable candidate for treatment of infl ammatory disorders, and the anti-infl ammatory activity of hWRF may be a function of the inhibition of iNOS and COX-2 expression via inactivation with NF-κB. Therefore, hWRF, a natural product, may serve as safe and effective anti-infl ammatory agent, which could be used in functional food or for therapeutic purposes.
